X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4680) 4680
Book Review (1170) 1170
Publication (471) 471
Newsletter (67) 67
Conference Proceeding (19) 19
Book Chapter (18) 18
Magazine Article (14) 14
Newspaper Article (7) 7
Dissertation (6) 6
Book / eBook (2) 2
Reference (2) 2
Government Document (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (3880) 3880
humans (3829) 3829
thalidomide - analogs & derivatives (2888) 2888
thalidomide (1998) 1998
thalidomide - therapeutic use (1931) 1931
male (1759) 1759
female (1614) 1614
oncology (1484) 1484
multiple myeloma - drug therapy (1343) 1343
middle aged (1341) 1341
hematology (1339) 1339
aged (1290) 1290
thalidomide - administration & dosage (1240) 1240
lenalidomide (1216) 1216
multiple myeloma (1067) 1067
treatment outcome (965) 965
thalidomide - adverse effects (925) 925
antineoplastic combined chemotherapy protocols - therapeutic use (912) 912
adult (897) 897
bortezomib (815) 815
antineoplastic agents - therapeutic use (762) 762
thalidomide - pharmacology (761) 761
animals (747) 747
therapy (633) 633
aged, 80 and over (567) 567
cancer (540) 540
care and treatment (507) 507
dexamethasone - administration & dosage (491) 491
pharmacology & pharmacy (486) 486
dexamethasone (457) 457
chemotherapy (452) 452
multiple-myeloma (436) 436
stem-cell transplantation (427) 427
drug therapy (388) 388
angiogenesis inhibitors - therapeutic use (380) 380
abridged index medicus (371) 371
survival (371) 371
multiple myeloma - pathology (367) 367
immunologic factors - therapeutic use (362) 362
antineoplastic combined chemotherapy protocols - adverse effects (354) 354
research (352) 352
mice (349) 349
medicine & public health (342) 342
angiogenesis (325) 325
recurrence (323) 323
disease-free survival (299) 299
hematology, oncology and palliative medicine (295) 295
analysis (293) 293
prognosis (293) 293
clinical trials as topic (292) 292
multiple myeloma - therapy (287) 287
antineoplastic agents - adverse effects (285) 285
myelodysplastic syndromes - drug therapy (283) 283
multiple myeloma - mortality (271) 271
plus dexamethasone (267) 267
angiogenesis inhibitors (266) 266
dose-response relationship, drug (262) 262
antineoplastic agents - pharmacology (257) 257
transplantation (257) 257
boronic acids - therapeutic use (247) 247
pyrazines - therapeutic use (247) 247
health aspects (245) 245
necrosis-factor-alpha (231) 231
drug therapy, combination (225) 225
immunosuppressive agents - therapeutic use (224) 224
article (223) 223
antineoplastic combined chemotherapy protocols - administration & dosage (222) 222
efficacy (219) 219
expression (219) 219
myelodysplastic syndromes (219) 219
analogs (218) 218
clinical trials (217) 217
disease progression (215) 215
remission induction (215) 215
tnf-alpha (215) 215
combination (214) 214
dexamethasone - therapeutic use (213) 213
antineoplastic agents - administration & dosage (210) 210
cell line, tumor (208) 208
cells (208) 208
trial (206) 206
retrospective studies (205) 205
immunology (204) 204
boronic acids - administration & dosage (203) 203
pyrazines - administration & dosage (202) 202
pomalidomide (198) 198
drug administration schedule (195) 195
thalidomide analogs (194) 194
survival analysis (193) 193
risk factors (192) 192
apoptosis (191) 191
myelodysplastic syndromes - genetics (191) 191
survival rate (191) 191
dermatology (185) 185
multiple myeloma - diagnosis (182) 182
myeloma (181) 181
follow-up studies (179) 179
medicine, general & internal (179) 179
in-vitro (178) 178
dosage and administration (176) 176
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4540) 4540
Japanese (100) 100
French (37) 37
German (36) 36
Chinese (27) 27
Spanish (19) 19
Czech (18) 18
Polish (5) 5
Danish (2) 2
Hungarian (2) 2
Portuguese (2) 2
Italian (1) 1
Korean (1) 1
Russian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 10/2017, Volume 35, Issue 29, pp. 3279 - 3279
Journal Article
Letters in Organic Chemistry, ISSN 1570-1786, 02/2013, Volume 10, Issue 2, pp. 139 - 146
A novel series of N-alkyl/aryl substituted phthalimide analogs containing 2-bromopyridyl functionality were synthesized applying optimized Buchwald-Hartwig... 
Palladium acetate | BINAP | Phthalimide | In vitro antiproliferation | 1ZXM | In silico | Buchwald-Hartwig (C-N) coupling | Topoisomerase II | CHEMISTRY, ORGANIC | CARBOLINES | in silico | phthalimide | in vitro antiproliferation | TNF-ALPHA PRODUCTION | topoisomerase II | palladium acetate | THALIDOMIDE ANALOGS | INHIBITORS | PHTHALIMIDE DERIVATIVES
Journal Article
RSC Advances, 01/2019, Volume 9, Issue 34, pp. 19869 - 19881
Antimicrobial resistance (AMR) presents as a serious threat to global public health, which urgently demands action to develop alternative antimicrobial... 
Escherichia coli | Adjuvants | Antimicrobial agents | Antiinfectives and antibacterials | Proteins | Inhibitors | Antibiotics | Computation | Natural products | RecA protein | Docking | Bacteria | Biological computing | Thalidomide | Binding sites | Public health | Acetone
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 13, pp. 1503 - 1512
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 5/2009, Volume 106, Issue 21, pp. 8573 - 8578
Journal Article
Chemical Science, ISSN 2041-6520, 01/2015, Volume 6, Issue 2, pp. 1043 - 1048
We report on the self-disproportionation of enantiomers (SDE) of non-racemic thalidomide (1) and 3'-fluorothalidomide (2) under the conditions of... 
Fluorine | Analogue | Polarity | Enantiomers | Atomic structure | Fluorination | Thalidomide | Chromatography
Journal Article
Blood, ISSN 0006-4971, 2013, Volume 121, Issue 11, pp. 1961 - 1967
Journal Article
BRITISH JOURNAL OF CANCER, ISSN 0007-0920, 03/2004, Volume 90, Issue 5, pp. 955 - 961
We assessed the safety, tolerability and efficacy of the immunomodulatory drug, CC-5013 (REVIMID(TM)), in the treatment of patients with metastatic malignant... 
immunomodulation | CC-5013 | REFRACTORY MULTIPLE-MYELOMA | LOW-DOSE THALIDOMIDE | COLONY-STIMULATING FACTOR | CROHNS-DISEASE | DRUG-RESISTANCE | AGENT THALIDOMIDE | T-cell activation | TRIAL | phase 1 | CYTOKINE PRODUCTION | THERAPY | thalidomide | ONCOLOGY | DOUBLE-BLIND | cytokines
Journal Article
Journal Article
European Journal of Medicinal Chemistry, ISSN 0223-5234, 2009, Volume 44, Issue 9, pp. 3533 - 3542
Journal Article
Journal Article